BREVIBLOC

Baxter Healthcare Corporation🇺🇸 United States

FDA Page

Effective Date: Mar 14, 2025
Approval ID: 220a07b8-5c68-41a3-8705-fd91f14c50b4
Products: 2 registered
Version: 15

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use BREVIBLOC injection safely and effectively. See full prescribing information for BREVIBLOC injection.BREVIBLOC (Esmolol Hydrochloride) injection, for intravenous useInitial U.S. Approval: 1986

Quick Stats

Total Products2

Labelers3

Label Sections34

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.